Skip to main content
SpringerLink
Log in

Different Roles for Plasminogen Activators and Metalloproteinases in Melanoma Metastasis

  • Chapter
Attempts to Understand Metastasis Formation I

Part of the book series: Current Topics in Microbiology 213/I and Immunology ((CT MICROBIOLOGY,volume 213/1))

Abstract

The architecture of normal tissues is maintained by interactions between cells and the extracellular matrix (ECM). In this cooperation, cells produce and assemble the components of the ECM whereas the ECM stabilizes the physical structure of tissues and also regulates the behavior of cells (McDonald 1988, Adams and Watt 1993). Transformed cells can alter the composition and structural integrity of adjacent matrix promoting tumor progression. Enzymes produced by tumor cells can degrade different components of the ECM, such as collagens, glycoproteins and proteoglycans, and such matrix-degrading enzymes were shown to contribute to tumor invasion and metastasis in various experimental systems (for review of the extensive literature see Mareel et al. 1991; Mignatti and Rifkin 1993). The current view emerging from these studies is that the concerted action of several different enzymes, whose activities are modulated by complex control mechanisms, is required in malignancy. The functional role of the enzymatic degradation of ECM by tumor cells has been thought to be the dissolution of occluding matrix, thus enabling the cells to invade into the interstitial matrix of the mesenchyme at the site of a primary tumor, to cross the basement membrane of blood vessels in the process of intra- and extravasation and lastly to invase into the mesenchyme of a secondary site. More recently, it has been recognized that enzymatically altered matrix also provides a complex source of molecular information that can modulate tumor cell behavior including adhesion, survival, growth and migration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams JC, Watt FM (1993) Regulation of development and differentiation by the extracellular matrix. Development 117: 1183–1198.

    PubMed  CAS  Google Scholar 

  • Anderson RGW (1993) Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90: 10909–10913.

    Article  PubMed  CAS  Google Scholar 

  • Aoyama A, Chen WT (1990) A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci USA 87: 8296–8300.

    Article  PubMed  CAS  Google Scholar 

  • Axelrod JH, Reich R, Miskin R (1989) Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol Cell Biol 9:2133–2141.

    PubMed  CAS  Google Scholar 

  • Bizik J, Stephens RW, Grofova M, Vaheri A (1993) Binding of tissue-type plasminogen activator to human melanoma cells. J Cell Biochem 51: 326–335.

    Article  PubMed  CAS  Google Scholar 

  • Blasi F (1993) Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15: 105–111.

    Article  PubMed  CAS  Google Scholar 

  • Boike G, Lah T, Sloane BF, Rozhin J, Honn K, Guirguis R, Stracke ML, Liotta LA, Schiffman E (1991) A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumor cells. Melanoma Res 1: 333–340.

    Article  Google Scholar 

  • Chirivi RGS, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R (1994) Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58: 460–464.

    Article  PubMed  CAS  Google Scholar 

  • Clark WH (1991) Tumour progression and the nature of cancer. Br J Cancer 64: 631–644.

    Article  PubMed  CAS  Google Scholar 

  • Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD (1993) Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90: 5021–5025.

    Article  PubMed  CAS  Google Scholar 

  • Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activation, tissue degradation and cancer. Adv Cancer Res 44: 139–266.

    Article  PubMed  Google Scholar 

  • DeClerck YA, Imren S (1994) Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 30A: 2170–2180.

    Article  PubMed  CAS  Google Scholar 

  • DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708.

    PubMed  CAS  Google Scholar 

  • Delbaldo C, Massouye I, Saurat J-H, Vassalli J-D, Sappino A-P (1994) Plasminogen activation in melanocytic neoplasia. Cancer Res 54: 4547–4552.

    PubMed  CAS  Google Scholar 

  • Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59: 329–341.

    Article  PubMed  CAS  Google Scholar 

  • De Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidie UH, Ruiter DJ, Van Muijen GNP (1994) Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144: 70–81.

    PubMed  Google Scholar 

  • Ellis V, Pyke C, Eriksen J, Solberg H, Danø K (1992) The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 667: 13–31.

    Article  PubMed  CAS  Google Scholar 

  • Frisch SM, Werb Z (1989) Molecular biology of collagen degradation. In: Olsen BR, Nimni ME (eds) Collagen: molecular biology, vol IV. CRC Press, Boca Raton, Florida, pp. 85–105.

    Google Scholar 

  • Hajjar KA, Jacovina AT, Chacko J (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269: 21191–21197.

    CAS  Google Scholar 

  • Hearing VJ, Law JW, Corti A, Appella E, Blasi F (1988) Modulation of metastastic potential by cell surface urokinase of murine melanoma cells. Cancer Res 48: 1270–1278.

    PubMed  CAS  Google Scholar 

  • Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajima D, Misiorowski RL, Seftor REB, StetlerStevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz A, Lotan A (1990) Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factors. Cancer Res 50: 4121–4130.

    PubMed  CAS  Google Scholar 

  • Herlyn M (1993) Molecular and cellular biology of melanoma. Landes. Austin, Texas.

    Google Scholar 

  • Hoal-Van Helden EG, Wilson EL, Dowdle EB (1986) Characterization of seven human melanoma cell lines: melanogenesis and secretion of plasminogen activators. Br J Cancer 54: 287–295.

    Article  PubMed  CAS  Google Scholar 

  • Johnson MD, Kim HR, Chester L, Tsao WG, Bouck N, Polverini PJ (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194–202.

    Article  PubMed  CAS  Google Scholar 

  • Khokha R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16–F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299–304.

    Article  PubMed  CAS  Google Scholar 

  • Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P (1992a) Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in B16–F10 melanoma cells. J Natl Cancer Inst 84: 1017–1022.

    Article  PubMed  CAS  Google Scholar 

  • Khokha R, Zimmer MJ, Wilson SM, Chambers A (1992b) Up-regulation of TIMP-1 expression in B16–F10 melanoma cells supresses their metastatic ability in chick embryo. Clin Exp Metastasis 10:365–304.

    Article  PubMed  CAS  Google Scholar 

  • Kirchheimer JC, Wojta J, Christ G, Binder BR (1989) Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line. Proc Natl Acad Sci USA 86: 5424–5428.

    Article  PubMed  CAS  Google Scholar 

  • Koop S, Khokha R, Schmidt EE, MacDonald IC, Morris VL, Chambers AF, Groom AC (1994) Overexpression of metalloproteinase inhibitor in B16–F10 cells does not affect extravasation but reduces tumor growth. Cancer Res 54: 4791–4797.

    PubMed  CAS  Google Scholar 

  • Kwaan HC (1992) The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291–311.

    Article  PubMed  CAS  Google Scholar 

  • Laug WE, Cao XR, Yu YB, Shimada H, Kruithof EKO (1993) Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2. Cancer Res 53: 6051–6057.

    PubMed  CAS  Google Scholar 

  • Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327–336.

    Article  PubMed  CAS  Google Scholar 

  • Lisanti MP, Scherer PE, Tang Z, Sargiacomo M (1994) Caveolae, caveolin and caveolain-rich membrane domains: a signalling hypothesis. Trends Cell Biol 4: 231–235.

    Article  PubMed  CAS  Google Scholar 

  • MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS (1995) The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174–4181.

    PubMed  CAS  Google Scholar 

  • Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP (1990) Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50: 5997–6001.

    PubMed  CAS  Google Scholar 

  • Matrisian LM (1992) The matrix-degrading metalloproteinasess. Bioessays 14: 455–463.

    Article  PubMed  CAS  Google Scholar 

  • Mareel MM, De Baetselier P, Van Roy FM (1991) Cellular activities implicated in invasion and metastasis. In: Mareel MM, De Baetselier P, Van Roy FM (eds) Mechanisms of invasion and metastasis. CRC Press, Boca Raton, Florida, pp 73–219.

    Google Scholar 

  • McDonald J (1988) Extracellular matrix assembly. Annu Rev Cell Biol 4: 183–207.

    Article  PubMed  CAS  Google Scholar 

  • Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G (1991) Urokinase-type and tissue type plasminogen activators are essential for in vitro invasion of human melanoma cells. Exp Cell Res 192: 453–459.

    Article  PubMed  CAS  Google Scholar 

  • Meissauer A, Kramer MD, Schirrmacher V, Brunner G (1992) Generation of cell surface-bound plasmin by cell associated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma invasiveness in vitro. Exp Cell Res 199: 179–190.

    Article  PubMed  CAS  Google Scholar 

  • Menrad A, Speicher D, Wacker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53: 1450–1455.

    PubMed  CAS  Google Scholar 

  • Mignatti P, Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161–195.

    PubMed  CAS  Google Scholar 

  • Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487–498.

    Article  PubMed  CAS  Google Scholar 

  • Miles LA, Dahlberg CM, Plescia J, Felez, Kato K, Plow EF (1991) Role of cell surface lysines in plasminogen binding to cells: identification of oc-enolase as a candidate plasminogen receptor. Biochemistry 30: 1682–1686.

    Article  PubMed  CAS  Google Scholar 

  • Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT (1994) A potential marker of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54: 5702–5710.

    PubMed  CAS  Google Scholar 

  • Montgomery AMP, De Clerck YA, Langley KE, Reisfeld RA, Mueller BM (1993) Melanoma-mediated dissolution of extracellular matrix. Contribution of urokinase-dependent and metalloproteinase dependent proteolytic pathways. Cancer Res 53: 693–700.

    CAS  Google Scholar 

  • Montgomery AMP, Mueller BM, Reisfeld RA, Taylor SM, De Clerck YA (1994a) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 54: 5467–5473.

    PubMed  CAS  Google Scholar 

  • Montgomery AMP, Reisfeld RA, Cheresh DA (1994b) Integrin ocvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 91: 8856–8860.

    Article  PubMed  CAS  Google Scholar 

  • Moses MA, Langer R (1991) A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 47: 230–235.

    Article  PubMed  CAS  Google Scholar 

  • Mueller BM, Romerdahl CA, Trent JM, Reisfeld RA (1991) Suppression of spontaneous melanoma metastasis in SCID mice with an antibody to the epidermal growth factor receptor. Cancer Res 51: 2193–2198.

    PubMed  CAS  Google Scholar 

  • Mueller BM, Yu YB, Laug WE (1995) Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci USA 92: 205–209.

    Article  PubMed  CAS  Google Scholar 

  • Murphy G, Willenbrock F, Crabbe T, O’Shea M, Ward R, Atkinson S, O’Connell J, Reynolds JJ (1994) Regulation of matrix metalloproteinase activity. Ann NY Acad Sci 732: 31–41.

    Article  PubMed  CAS  Google Scholar 

  • Nakajima M, Irimura T, Nicolson GL (1988) Heparanases and tumor metastasis. J Cell Biochem 36: 157–167.

    Article  PubMed  CAS  Google Scholar 

  • Ossowski L (1992) Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. Cancer Res 52: 6754–6760.

    PubMed  CAS  Google Scholar 

  • Ossowki L, Reich E (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35: 611–619.

    Article  Google Scholar 

  • Ossowski L Russo-Payne H, Wilson EL (1991) Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res 51: 274–281.

    PubMed  CAS  Google Scholar 

  • Pauli BU, Arsenis C, Hohberger LH, Schwart DE (1986) Connective tissue degradation by invasive rat bladder carcinomas: action of nonspecific proteinases on collagenous matrices. Cancer Res 46: 2005–2012.

    PubMed  CAS  Google Scholar 

  • Quax PHA, Van Muijen GNP, Weening-Verhoeff EJD, Lund LR, Dano K, Ruiter DJ, Verheijen JH (1991) Metastatic behaviour of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 115: 191–199.

    Article  PubMed  CAS  Google Scholar 

  • Ray JA, Stetler-Stevenson WG (1994) TIMP-2 expression modulates human melanoma cell adhesion and motility. Ann NY Acad Sci 732: 233–247.

    Article  PubMed  CAS  Google Scholar 

  • Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC, Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastastic cells. Cancer Res 48: 3307–3312.

    PubMed  CAS  Google Scholar 

  • Rijken DC, Collen D (1981) Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 256: 7035–7041.

    PubMed  CAS  Google Scholar 

  • Rozhin J, Wade R, Honn KV, Sloane BF (1989) Membrane associated cathepsin L: a role in metastasis of melanomas. Biochem Biophys Res Commun 164: 556–561.

    Article  PubMed  CAS  Google Scholar 

  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61–65.

    Article  PubMed  CAS  Google Scholar 

  • Seftor REB, Seftor EA, Gehlsen KR, Stetler-Stevenson WG, Brown PD, Ruoslathi E, Hendrix MJC (1992) Role of the ocvβ3 integrin in human melanoma invasion. Proc Natl Acad Sci USA 89: 1557–1561.

    Article  PubMed  CAS  Google Scholar 

  • Seftor REB, Seftor EA, Stetler-Stevenson WG, Hendrix MJC (1993) The 72 kDa type IV collagenase is modulated via differential expression of αvβ3 and α5β1 integrins during human melanoma cell invasion. Cancer Res 53: 3411–3415.

    PubMed  CAS  Google Scholar 

  • Sloane BF, Moin K, Krepela E, Rozhin J (1990) Cathepsin B and its endogenous inhibitors: The role in tumor malignancy. Cancer Metastasis Rev 9: 333–352.

    Article  PubMed  CAS  Google Scholar 

  • Stahl A, Mueller BM (1994) Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res 54: 3066–3071.

    PubMed  CAS  Google Scholar 

  • Stahl A, Mueller BM (1995) The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol 129: 335–344.

    Article  PubMed  CAS  Google Scholar 

  • Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541–573.

    Article  PubMed  CAS  Google Scholar 

  • Testa JE, Quigley JP (1990) The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastais Rev 9: 35–367.

    Article  Google Scholar 

  • Tsushima H, Hyodoh F, Yoshida E, Ueki A, Hopsu-Havu VK (1991a) Inacative cathepsin B-like enzyme in human melanoma culture medium. Melanoma Res 1: 341–347.

    Article  Google Scholar 

  • Tsushima H, Ueki A, Matsuoka Y, Minara H, Hopsu-Havu VK (1991b) Characterization of a cathepsin-H-like enzyme from a human melanoma cell line. Int J Cancer 48: 726–732.

    Article  PubMed  CAS  Google Scholar 

  • Vaheri A, Tapiovaara H, Myohanen H, Bizik J (1994) ∂2-Macroglobulin in the regulation of pericellular plasminogen activation of human tumor cells. Ann NY Acad Sci 737: 409–418.

    Article  PubMed  CAS  Google Scholar 

  • Vassalli J-D, Sappino A-P, Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest 88: 1067–1072.

    Article  PubMed  CAS  Google Scholar 

  • Wang X, Fu X, Brown PD, Crimmin MJ, Hoffman RM (1994) Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54: 4726–4728.

    PubMed  CAS  Google Scholar 

  • Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor REB, Nakajima M, Hendrix MJC (1991) Characterization of a highly invasive and spontaneously metastastic human malignant melanoma cell line. Int J Cancer 47: 227–237.

    Article  PubMed  CAS  Google Scholar 

  • Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM (1994) Modulation of matrilysin levels in colon carcinoma cell affects tumorigenicity in vivo. Cancer Res 54: 48052–4812.

    Google Scholar 

  • Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154.

    PubMed  CAS  Google Scholar 

  • Yu, H, Schultz RM (1990) Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res 50: 7623–7633.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, The Scripps Research Institute, 10666 N. Torrey Pines Road, IMM13, La Jolla, CA, 92037, USA

    B. M. Mueller

Authors
  1. B. M. Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Basel Institute for Immunology, Grenzacherstraße 487, CH-4005, Basel, Switzerland

    Ursula Günthert Ph.D., P.D.

  2. Max-βDelbrūck-Centrum für Molekulare Medizin, Robert-Rōssle-Straße 10, D-13122, Berlin, Germany

    Walter Birchmeier Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mueller, B.M. (1996). Different Roles for Plasminogen Activators and Metalloproteinases in Melanoma Metastasis. In: Günthert, U., Birchmeier, W. (eds) Attempts to Understand Metastasis Formation I. Current Topics in Microbiology 213/I and Immunology, vol 213/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61107-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61107-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64697-3

  • Online ISBN: 978-3-642-61107-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation